{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:09:24Z","timestamp":1782569364304,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T00:00:00Z","timestamp":1374883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10741-013-9401-z","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T12:23:25Z","timestamp":1374841405000},"page":"703-714","source":"Crossref","is-referenced-by-count":31,"title":["Dilated cardiomyopathy update: infectious-immune theory revisited"],"prefix":"10.1007","volume":"18","author":[{"given":"Chuichi","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,27]]},"reference":[{"key":"9401_CR1","unstructured":"Kawai C (1971) Idiopathic cardiomyopathy. A study of the infectious-immune theory as a cause of the disease. Jpn Circ J 35:765\u2013770. ISSN:00471828"},{"key":"9401_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.99.8.1091","volume":"99","author":"C Kawai","year":"1999","unstructured":"Kawai C (1999) From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Learning from the past for the future. Circulation 99:1091\u20131100. doi: 10.1161\/01.CIR.99.8.1091","journal-title":"Circulation"},{"key":"9401_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1126\/science.285.5424.26","volume":"285","author":"J Cohen","year":"1999","unstructured":"Cohen J (1999) The scientific challenge of hepatitis C. Science 285:26\u201330. doi: 10.1126\/science.285.5424.26","journal-title":"Science"},{"key":"9401_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","volume":"341","author":"MJ Alter","year":"1999","unstructured":"Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS (1999) The prevalence of hepatitis C virus infection in the United States, 1998 through 1994. N Eng J Med 341:556\u2013562. doi: 10.1056\/NEJM199908193410802","journal-title":"N Eng J Med"},{"key":"9401_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.294.5542.506","volume":"294","author":"C Crabb","year":"2001","unstructured":"Crabb C (2001) Infectious diseases. Hard-won advances spark excitement about hepatitis C. Science 294:506\u2013507. doi: 10.1126\/science.294.5542.506","journal-title":"Science"},{"key":"9401_CR6","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.92.9.2519","volume":"92","author":"A Matsumori","year":"1995","unstructured":"Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92:2519\u20132525. doi: 10.1161\/01.CIR.92.9.2519","journal-title":"Circulation"},{"key":"9401_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.RES.0000156077.54903.67","volume":"96","author":"A Matsumori","year":"2005","unstructured":"Matsumori A (2005) Hepatitis C virus infection and cardiomyopathies. Circ Res 96:144\u2013147. doi: 10.1161\/01.RES.0000156077.54903.67","journal-title":"Circ Res"},{"key":"9401_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2005.11.004","volume":"12","author":"A Matsumori","year":"2006","unstructured":"Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW (2006) Myocarditis and heart failure associated with hepatitis C virus infection. J Cardiac Fail 12:293\u2013298","journal-title":"J Cardiac Fail"},{"issue":"1","key":"9401_CR9","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.25011\/cim.v34i1.14910","volume":"34","author":"L Wang","year":"2011","unstructured":"Wang L, Geng J, Li J, Li T, Matsumori A, Chang Y, Lu F, Zhuang H (2011) The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin Invest Med 34(1):E30\u2013E37","journal-title":"Clin Invest Med"},{"key":"9401_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cvdpc.2009.02.002","volume":"4","author":"A Matsumori","year":"2009","unstructured":"Matsumori A (2009) Global alert and response network for hepatitis C virus-derived heart diseases: a call to action. CVD Prev Control 4:109\u2013118. doi: 10.1016\/j.cvdpc.2009.02.002","journal-title":"CVD Prev Control"},{"key":"9401_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","volume":"125","author":"JM Hui","year":"2003","unstructured":"Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan G, George J (2003) Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 125:1695\u20131704. doi: 10.1053\/j.gastro.2003.08.032","journal-title":"Gastroenterology"},{"issue":"4","key":"9401_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jsha.2011.04.005","volume":"23","author":"A Saleh","year":"2011","unstructured":"Saleh A, Matsumori A, Negm H, Fouad H, Onsy A, Shalaby M (2011) Assessment of cardiac involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study. J Saudi Heart Assoc 23(4):217\u2013223. doi: 10.1016\/j.jsha.2011.04.005","journal-title":"J Saudi Heart Assoc"},{"key":"9401_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cvdpc.2010.04.005","volume":"5","author":"A Matumori","year":"2010","unstructured":"Matumori A, Shimada M, Obata T (2010) Leukocytes are the major target of hepatitis C virus infection: possible mechanism of multiorgan involvement including the heart. CVD Prev Control 5:51\u201358. doi: 10.1016\/jcvdpc.2010.04.005","journal-title":"CVD Prev Control"},{"key":"9401_CR14","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.143.8.2714","volume":"143","author":"GJ Freeman","year":"1989","unstructured":"Freeman GJ, Freeman AS, Segil JM, Lee G, Whitman JF, Nadler LM (1989) B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714\u20132722","journal-title":"J Immunol"},{"key":"9401_CR15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/366076a0","volume":"366","author":"M Azuma","year":"1993","unstructured":"Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanler LL, Somoza C (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76\u201379. doi: 10.1038\/366076a0","journal-title":"Nature"},{"key":"9401_CR16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.71.6.1247","volume":"71","author":"C Kishimoto","year":"1985","unstructured":"Kishimoto C, Kuribayashi K, Masuda T, Tomioka N, Kawai C (1985) Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB\/c-nu\/nu mice. Circulation 71:1247\u20131254. doi: 10.1161\/01.CIR.71.6.1247","journal-title":"Circulation"},{"key":"9401_CR17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.CIR.66.2.355","volume":"66","author":"A Matsumori","year":"1982","unstructured":"Matsumori A, Kawai C (1982) An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA\/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66:355\u2013360. doi: 10.1161\/01.CIR.66.2.355","journal-title":"Circulation"},{"key":"9401_CR18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/01.CIR.100.13.1443","volume":"100","author":"M Hara","year":"1999","unstructured":"Hara M, Matsumori A, Ono K, Kido H, Hwang MW, Miyamoto T, Iwasaki A, Okada M, Nakatani K, Sasayama S (1999) Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 100:1443\u20131449. doi: 10.1161\/01.CIR.100.13.1443","journal-title":"Circulation"},{"key":"9401_CR19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1253\/circj.67.881","volume":"67","author":"K Kitaura-Inenaga","year":"2003","unstructured":"Kitaura-Inenaga K, Hara M, Higuchi H, Yamamoto K, Yamaki A, Ono K, Nakano A, Kinoshita M, Sasayama S, Matsumori A (2003) Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ J 67:881\u2013884. doi: 10.1253\/circj.67.881","journal-title":"Circ J"},{"key":"9401_CR20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-3-642-73610-0_35","volume-title":"New concepts in viral heart disease","author":"A Matsumori","year":"1988","unstructured":"Matsumori A, Okada I, Kawai C, Crumpacker CS, Abelmann WF (1988) Animal models for therapeutic trials of viral myocarditis: effect of ribavirin and alpha interferon on coxsackievirus B3 and encephalomyocarditis virus myocarditis. In: Schultheiss H-P (ed) New concepts in viral heart disease. Springer, Berlin, pp 377\u2013384"},{"key":"9401_CR21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/01.CIR.79.6.1237","volume":"79","author":"JW Newburger","year":"1989","unstructured":"Newburger JW, Sanders SP, Burns JC, Parness IA, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation 79:1237\u20131246. doi: 10.1161\/01.CIR.79.6.1237","journal-title":"Circulation"},{"key":"9401_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","volume":"89","author":"N Drucker","year":"1994","unstructured":"Drucker N, Colan S, Lewis A, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newberger JW (1994) Gamma globulin treatment of acute myocarditis in the pediatric population. Circulation 89:252\u2013257. doi: 10.1161\/01.CIR.89.1.252","journal-title":"Circulation"},{"key":"9401_CR23","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","volume":"103","author":"DM McNamara","year":"2001","unstructured":"McNamara DM, Holublcov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosco K, Tokarczyk T, Kessler P, Mann DL, Feldman AM, for the intervention in Myocarditis and Acute Cardiomyopathy (IMAC) Investigators (2001) Controlled trial of intravenous immune globulin. Circulation 103:2254\u20132259. doi: 10.1161\/01.CIR.103.18.2254","journal-title":"Circulation"},{"key":"9401_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","volume":"333","author":"JW Mason","year":"1995","unstructured":"Mason JW, O\u2019Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, The Myocarditis Treatment Trial Investigators (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269\u2013275","journal-title":"N Engl J Med"},{"key":"9401_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","volume":"107","author":"A Frustaci","year":"2003","unstructured":"Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857\u2013863. doi: 10.1161\/01.CIR.0000048147.15962.31","journal-title":"Circulation"},{"key":"9401_CR26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","volume":"59","author":"I Kindermann","year":"2012","unstructured":"Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Kingel K, Kandolf R, Sechtem U, Cooper LT, Boehm M (2012) Update on myocarditis. J Am Coll Cardiol 59:779\u2013792. doi: 10.1016\/j-jacc.2011.09.074","journal-title":"J Am Coll Cardiol"},{"key":"9401_CR27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","volume":"102","author":"LT Cooper Jr","year":"2008","unstructured":"Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mulien GM, Jasky B, Bailey KR, Cunningham MW, Giant Cell DecGW Myocarditis Treatment Trial Investigators (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535\u20131539. doi: 10.1016\/j.amjcard.2008.07.041","journal-title":"Am J Cardiol"},{"key":"9401_CR28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00059-012-3658-1","volume":"37","author":"LT Cooper Jr","year":"2012","unstructured":"Cooper LT Jr, EIAmm C (2012) Giant cell myocarditis. Herz 37:632\u2013636. doi: 10.1007\/s00059-012-3658-1","journal-title":"Herz"},{"key":"9401_CR29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"A Frustaci","year":"2009","unstructured":"Frustaci A, Russo A, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995\u20132002. doi: 10.1093\/eurheartj\/ehp249","journal-title":"Eur Heart J"},{"key":"9401_CR30","doi-asserted-by":"crossref","unstructured":"Seizer P, Klingel K, Sauter M, Westermann D, Ochmann C, Schonberger T, Schleicher R, Stellos K, Schmidt EM, Borst O, Bigalke B, Kandolf R, Langer H, Gawaz M, May AE (2012) Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus-induced myocarditis. J Mol Cell Cardilol 53:6\u201314. doi: 10.1016\/j.yjmcc.2012.03.004 . Epub 2012 Mar 15","DOI":"10.1016\/j.yjmcc.2012.03.004"},{"key":"9401_CR31","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1161\/01.CIR.0000136824.73458.20","volume":"110","author":"R Deonarain","year":"2004","unstructured":"Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon\u03b2 in coxsackievirus B3 infection. Circulation 110:3540\u20133543. doi: 10.1161\/01.CIR.0000136824.73458.20","journal-title":"Circulation"},{"key":"9401_CR32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/res.89.10.850","volume":"89","author":"PP Liu","year":"2001","unstructured":"Liu PP, Le J, Nian M (2001) Nuclear factor-\u03baB decoy. Infiltrating the heart of the matter in inflammatory heart disease. Circ Res 89:850\u2013852. doi: 10.1161\/hh2201.100347","journal-title":"Circ Res"},{"key":"9401_CR33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.RES.82.10.1023","volume":"82","author":"R Morishita","year":"1998","unstructured":"Morishita R, Higaki J, Tomita N, Ogihara T (1998) Application of transcription factor \u2018decoy\u2019 strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 82:1023\u20131028. doi: 10.1161\/01.RES.8210.1023","journal-title":"Circ Res"},{"key":"9401_CR34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.RES.82.12.1349","volume":"82","author":"R Morishita","year":"1998","unstructured":"Morishita R (1998) Lessons from human arteries: how to design a gene therapy strategy for human treatment of cardiovascular disease. Circ Res 82:1349\u20131351. doi: 10.1161\/01.RES.82.12.1349","journal-title":"Circ Res"},{"key":"9401_CR35","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/sj.gt.3301566","volume":"8","author":"S Yoshimura","year":"2001","unstructured":"Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y, Sakai N, Ogihara T (2001) Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element \u2018decoy\u2019 of nuclear factor-\u03baB binding site as a novel molecular strategy. Gene Ther 8:1635\u20131642","journal-title":"Gene Ther"},{"key":"9401_CR36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nm0897-894","volume":"3","author":"R Morishita","year":"1997","unstructured":"Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T (1997) In vivo transfection of cis-element \u2018decoy\u2019 against nuclear factor-\u03baB binding site prevents myocardial infarction. Nat Med 3:894\u2013899. doi: 10.1038\/nmo897-894","journal-title":"Nat Med"},{"key":"9401_CR37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1253\/circj.68.683","volume":"68","author":"J Suzuki","year":"2004","unstructured":"Suzuki J, Ito H, Gotoh R, Morishita R, Egashira K, Isobe M (2004) Initial clinical cases of a NF-\u03baB decoy at the site of coronary stenting for the prevention of restenosis. Circ J 68:270\u2013271","journal-title":"Circ J"},{"key":"9401_CR38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jgm.1192","volume":"10","author":"K Egashira","year":"2008","unstructured":"Egashira K, Suzuki J, Ito H, Aoki M, Isobe M, Morishita R (2008) Long-term follow up of initial clinical cases with NF-\u03baB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 10:805\u2013809. doi: 10.1002\/jgm.1192","journal-title":"J Gene Med"},{"key":"9401_CR39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jgm.1266","volume":"11","author":"J Suzuki","year":"2009","unstructured":"Suzuki J, Tezuka D, Morishita R, Isobe M (2009) An initial case of suppressed restenosis with nuclear factor-\u03baB decoy transfection after percutaneous coronary intervention. J Gene Med 11:89\u201391. doi: 10.1002\/jgm.1266","journal-title":"J Gene Med"},{"key":"9401_CR40","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.gt.3301316","volume":"7","author":"J Suzuki","year":"2000","unstructured":"Suzuki J, Morishita R, Amano J, Kaneda Y, Isobe M (2000) Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Gene Ther 7:1847\u20131852","journal-title":"Gene Ther"},{"key":"9401_CR41","doi-asserted-by":"crossref","unstructured":"Suzuki J, Isobe M, Morishita R, Nagai R (2012) Application of nucleic acid drugs for organ transplantation. Curr Top Med Chem 12:1608\u20131612","DOI":"10.2174\/156802612803531478"},{"key":"9401_CR42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/hh2201.099373","volume":"89","author":"O Yokoseki","year":"2001","unstructured":"Yokoseki O, Suzuki J, Kitabayashi H, Watanabe N, Wada Y, Aoki M, Morishita R, Kaneda Y, Ogihara T, Futamatsu H, Kobayashi Y, Isobe M (2001) cis element decoy against nuclear factor-\u03baB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 89:899\u2013906. doi: 10.1161\/hh2201.099373","journal-title":"Circ Res"},{"key":"9401_CR43","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.85.5.1918","volume":"85","author":"M Kodama","year":"1992","unstructured":"Kodama M, Matsumoto Y, Fujiwara M (1992) In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85:1918\u20131926. doi: 10.1161\/01.CIR.85.5.1918","journal-title":"Circulation"},{"key":"9401_CR44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","volume":"115","author":"TF Luescher","year":"2007","unstructured":"Luescher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R (2007) Drug-eluting stent and coronary thrombosis. Biological mechanisms and clinical implications. Circulation 115:1051\u20131058. doi: 10.1161\/CIRCULATIONAHA.106.675934","journal-title":"Circulation"},{"key":"9401_CR45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ahj.2007.02.016","volume":"153","author":"V Pasceri","year":"2007","unstructured":"Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, DiSciascio G (2007) Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153:749\u2013754","journal-title":"Am Heart J"},{"key":"9401_CR46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1540-8183.2007.00225.x","volume":"20","author":"MB Leon","year":"2007","unstructured":"Leon MB (2007) Late thrombosis a concern with drug-eluting stents. J Interv Cardiol 20:26\u201329. doi: 10.1111\/j.1540-8183.2007.00225.x","journal-title":"J Interv Cardiol"},{"key":"9401_CR47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.CIR.96.2.542","volume":"96","author":"J Mueller","year":"1997","unstructured":"Mueller J, Wallukat G, Weng Y-G, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R (1997) Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96:542\u2013549. doi: 10.1161\/01.CIR.96.2.542","journal-title":"Circulation"},{"key":"9401_CR48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-5273(96)02598-3","volume":"54","author":"G Wallukat","year":"1996","unstructured":"Wallukat G, Reinke P, Doerffel WV, Luther HP, Bestvater K, Felix SB, Baumann G (1996) Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 54:191\u2013195","journal-title":"Int J Cardiol"},{"key":"9401_CR49","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","volume":"347","author":"G Wallukat","year":"2002","unstructured":"Wallukat G, Mueller J, Hetzer R (2002) Specific removal of \u03b21-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy (letter). N Engl J Med 347:1806","journal-title":"N Engl J Med"},{"key":"9401_CR50","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1161\/01.CIR.95.8.1994","volume":"95","author":"MV Doerffel","year":"1997","unstructured":"Doerffel MV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P (1997) Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95:1994\u20131997. doi: 10.1161\/01.CIR.95.8.1994","journal-title":"Circulation"},{"key":"9401_CR51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijcard.2004.03.001","volume":"97","author":"WV Doerffel","year":"2004","unstructured":"Doerffel WV, Wallukat G, Doerffel Y, Felix SB, Baumann G (2004) Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol 97:529\u2013534. doi: 10.1061\/j.ijcard.2004.03.001","journal-title":"Int J Cardiol"},{"key":"9401_CR52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","volume":"101","author":"J Mueller","year":"2000","unstructured":"Mueller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385\u2013391. doi: 10.1161\/01.CIR.101.4.385","journal-title":"Circulation"},{"key":"9401_CR53","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/01.CIR.103.22.2681","volume":"103","author":"A Staudt","year":"2001","unstructured":"Staudt A, Schaeper F, Stangl V, Plegemann A, Boehm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681\u20132686. doi: 10.1161\/01.CIR.103.22.2681","journal-title":"Circulation"},{"key":"9401_CR54","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","volume":"35","author":"SB Felix","year":"2000","unstructured":"Felix SB, Staudt A, Doerffel WV, Stangl V, Merkel K, Pohl M, Doecke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy. Three-month results from a randomized study. J Am Coll Cardiol 35:1590\u20131598. doi: 10.1016\/S0735-1097(00)00568-4","journal-title":"J Am Coll Cardiol"},{"key":"9401_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/rheumatology\/40.5.513","volume":"40","author":"S Schmaldienst","year":"2001","unstructured":"Schmaldienst S, Muellner M, Goldammer S, Spitzauer S, Banyai S, Hoerl WH, Derfler K (2001) Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? Rheumatology 40:513\u2013521. doi: 10.1093\/rheumatology\/40.5.513","journal-title":"Rheumatology"},{"key":"9401_CR56","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.0000036746.49449.64","volume":"106","author":"A Staudt","year":"2002","unstructured":"Staudt A, Boehm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallkat G, Baumann G, Felix SB (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyo-pathy. Circulation 106:2448\u20132453. doi: 10.1161\/01.CIR.0000036746.49449.64","journal-title":"Circulation"},{"key":"9401_CR57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","volume":"312","author":"JM McCord","year":"1985","unstructured":"McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159\u2013163. doi: 10.1056\/NEJM198501173120305","journal-title":"N Engl J Med"},{"key":"9401_CR58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0735-1097(01)01309-2","volume":"38","author":"I Schimke","year":"2001","unstructured":"Schimke I, Mueller J, Priem F, Kruse I, Schoen B, Stein J, Kunze R, Wallukat G, Hetzer R (2001) Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 38:178\u2013183. doi: 10.1016\/S0735-1097(01)01309-2","journal-title":"J Am Coll Cardiol"},{"key":"9401_CR59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4236\/wjcd.2012.24048","volume":"2","author":"H Kasai","year":"2012","unstructured":"Kasai H, Kashima Y, Izawa A, Tomita T, Miyashita Y, Koyama J, Takahashi M, Yoshio T, Yazaki Y, Higuchi M, Ikeda U (2012) Immunoadsorption therapy reduces oxidative stress in patients with dilated cardiomyopathy. World J Cardiovasc Dis 2:305\u2013312. doi: 10.4236\/wjcd.2012.24048","journal-title":"World J Cardiovasc Dis"},{"key":"9401_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.20268","volume":"26","author":"Y Nagatomo","year":"2011","unstructured":"Nagatomo Y, Baba A, Ito H, Naito K, Yoshizawa A, Kurita Y, Nakamura I, Monkawa T, Matsubara T, Wakabayashi Y, Ogawa S, Akaishi M, Yoshikawa T (2011) Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy. J Clin Apher 26:1\u20138. doi: 10.1002\/jca.20268","journal-title":"J Clin Apher"},{"key":"9401_CR61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","volume":"291","author":"H Nishimura","year":"2001","unstructured":"Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama A, Mizoguchi A, Hiai H, Minato N, Honjo T (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice. Science 291:319\u2013322. doi: 10.1126\/science.291.5502.319","journal-title":"Science"},{"key":"9401_CR62","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","volume":"9","author":"T Okazaki","year":"2003","unstructured":"Okazaki T, Tanaka Y, Nisio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9:1477\u20131483. doi: 10.1038\/nm955","journal-title":"Nat Med"},{"key":"9401_CR63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cvdpc.2011.02.004","volume":"6","author":"A Matsumori","year":"2011","unstructured":"Matsumori A, Shimada T, Hattori H, Shimada M, Mason JW (2011) Autoantibodies against cardiac troponin I in patients presenting with myocarditis. CVD Prev Control 6:41\u201346. doi: 10.1016\/j.cvdpc.2011.02.004","journal-title":"CVD Prev Control"},{"key":"9401_CR64","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.105.167587","volume":"112","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2005) ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Circulation 112:1825\u20131852. doi: 10.1161\/CIRCULATIONAHA.105.167587","journal-title":"Circulation"},{"key":"9401_CR65","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/CIR.0b013e3182507bec","volume":"125","author":"RO Bonow","year":"2012","unstructured":"Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MK, Wong JB (2012) ACCF\/AHA\/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures and the American Medical Association\u2013Physician Consortium for Performance Improvement. Circulation 125:2382\u20132401. doi: 10.1161\/CIR.0b013e3182507bec","journal-title":"Circulation"},{"key":"9401_CR66","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.101.17.2103","volume":"101","author":"SD Prabhu","year":"2000","unstructured":"Prabhu SD, Chandrasekar B, Murray DR, Freeman GL (2000) \u03b2-Adrenergic blockade in developing heart failure : effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101:2103\u20132109. doi: 10.1161\/01.CIR.101.17.2103","journal-title":"Circulation"},{"key":"9401_CR67","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT (2002) Aldosterone-induced inflammation in the rat heart. Am J Pathol 161:1773\u20131781","journal-title":"Am J Pathol"},{"key":"9401_CR68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for the Randomized Aldactone Evaluation Study Investigators (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709\u2013717. doi: 10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"key":"9401_CR69","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Pittman R, Hurley S, Kleiman J, Gatlin M, for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321. doi: 10.1056\/NEJMoa030207","journal-title":"N Engl J Med"},{"key":"9401_CR70","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","volume":"106","author":"G Suzuki","year":"2002","unstructured":"Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN (2002) Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 106:2967\u20132972. doi: 10.1161\/01.CIR.0000039104.56479.42","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-013-9401-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-013-9401-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-013-9401-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:54:57Z","timestamp":1688388897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-013-9401-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,27]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1007\/s10741-013-9401-z","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,27]]}}}